Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Sacco, S, Lampl, C, Maassen van den Brink, A, Caponnetto, V, Braschinsky, M, Ducros, A, Little, P, Pozo-Rosich, P, Reuter, U, Ruiz de la Torre, E, Sanchez Del Rio, M, Sinclair, AJ, Martelletti, P, Katsarava, Z, Burden and Attitude to Resistant and Refractory (BARR) Study Group & Edvinsson, L 2021, 'Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance', The Journal of Headache and Pain Online, bind 22, nr. 1, 39, s. 39. https://doi.org/10.1186/s10194-021-01252-4

APA

Sacco, S., Lampl, C., Maassen van den Brink, A., Caponnetto, V., Braschinsky, M., Ducros, A., Little, P., Pozo-Rosich, P., Reuter, U., Ruiz de la Torre, E., Sanchez Del Rio, M., Sinclair, A. J., Martelletti, P., Katsarava, Z., Burden and Attitude to Resistant and Refractory (BARR) Study Group, & Edvinsson, L. (2021). Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance. The Journal of Headache and Pain Online, 22(1), 39. [39]. https://doi.org/10.1186/s10194-021-01252-4

CBE

Sacco S, Lampl C, Maassen van den Brink A, Caponnetto V, Braschinsky M, Ducros A, Little P, Pozo-Rosich P, Reuter U, Ruiz de la Torre E, Sanchez Del Rio M, Sinclair AJ, Martelletti P, Katsarava Z, Burden and Attitude to Resistant and Refractory (BARR) Study Group, Edvinsson L. 2021. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance. The Journal of Headache and Pain Online. 22(1):39. https://doi.org/10.1186/s10194-021-01252-4

MLA

Vancouver

Author

Sacco, Simona ; Lampl, Christian ; Maassen van den Brink, Antoinette ; Caponnetto, Valeria ; Braschinsky, Mark ; Ducros, Anne ; Little, Patrick ; Pozo-Rosich, Patricia ; Reuter, Uwe ; Ruiz de la Torre, Elena ; Sanchez Del Rio, Margarita ; Sinclair, Alexandra J ; Martelletti, Paolo ; Katsarava, Zaza ; Burden and Attitude to Resistant and Refractory (BARR) Study Group ; Edvinsson, Lars. / Burden and attitude to resistant and refractory migraine : a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance. I: The Journal of Headache and Pain Online. 2021 ; Bind 22, Nr. 1. s. 39.

Bibtex

@article{6094c5b63fd643abb2d360d57db1b709,
title = "Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance",
abstract = "BACKGROUND: New treatments are currently offering new opportunities and challenges in clinical management and research in the migraine field. There is the need of homogenous criteria to identify candidates for treatment escalation as well as of reliable criteria to identify refractoriness to treatment. To overcome those issues, the European Headache Federation (EHF) issued a Consensus document to propose criteria to approach difficult-to-treat migraine patients in a standardized way. The Consensus proposed well-defined criteria for resistant migraine (i.e., patients who do not respond to some treatment but who have residual therapeutic opportunities) and refractory migraine (i.e., patients who still have debilitating migraine despite maximal treatment efforts). The aim of this study was to better understand the perceived impact of resistant and refractory migraine and the attitude of physicians involved in migraine care toward those conditions.METHODS: We conducted a web-questionnaire-based cross-sectional international study involving physicians with interest in headache care.RESULTS: There were 277 questionnaires available for analysis. A relevant proportion of participants reported that patients with resistant and refractory migraine were frequently seen in their clinical practice (49.5% for resistant and 28.9% for refractory migraine); percentages were higher when considering only those working in specialized headache centers (75% and 46% respectively). However, many physicians reported low or moderate confidence in managing resistant (8.1% and 43.3%, respectively) and refractory (20.7% and 48.4%, respectively) migraine patients; confidence in treating resistant and refractory migraine patients was different according to the level of care and to the number of patients visited per week. Patients with resistant and refractory migraine were infrequently referred to more specialized centers (12% and 19%, respectively); also in this case, figures were different according to the level of care.CONCLUSIONS: This report highlights the clinical relevance of difficult-to-treat migraine and the presence of unmet needs in this field. There is the need of more evidence regarding the management of those patients and clear guidance referring to the organization of care and available opportunities.",
keywords = "Consensus, Cross-Sectional Studies, Headache, Humans, Migraine Disorders/diagnosis, Surveys and Questionnaires, Migraine care, Migraine, Refractory migraine, Resistant migraine",
author = "Simona Sacco and Christian Lampl and {Maassen van den Brink}, Antoinette and Valeria Caponnetto and Mark Braschinsky and Anne Ducros and Patrick Little and Patricia Pozo-Rosich and Uwe Reuter and {Ruiz de la Torre}, Elena and {Sanchez Del Rio}, Margarita and Sinclair, {Alexandra J} and Paolo Martelletti and Zaza Katsarava and {Burden and Attitude to Resistant and Refractory (BARR) Study Group} and Lars Edvinsson",
year = "2021",
month = dec,
doi = "10.1186/s10194-021-01252-4",
language = "English",
volume = "22",
pages = "39",
journal = "The Journal of Headache and Pain Online",
issn = "1129-2377",
publisher = "SpringerOpen",
number = "1",

}

RIS

TY - JOUR

T1 - Burden and attitude to resistant and refractory migraine

T2 - a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

AU - Sacco, Simona

AU - Lampl, Christian

AU - Maassen van den Brink, Antoinette

AU - Caponnetto, Valeria

AU - Braschinsky, Mark

AU - Ducros, Anne

AU - Little, Patrick

AU - Pozo-Rosich, Patricia

AU - Reuter, Uwe

AU - Ruiz de la Torre, Elena

AU - Sanchez Del Rio, Margarita

AU - Sinclair, Alexandra J

AU - Martelletti, Paolo

AU - Katsarava, Zaza

AU - Burden and Attitude to Resistant and Refractory (BARR) Study Group

A2 - Edvinsson, Lars

PY - 2021/12

Y1 - 2021/12

N2 - BACKGROUND: New treatments are currently offering new opportunities and challenges in clinical management and research in the migraine field. There is the need of homogenous criteria to identify candidates for treatment escalation as well as of reliable criteria to identify refractoriness to treatment. To overcome those issues, the European Headache Federation (EHF) issued a Consensus document to propose criteria to approach difficult-to-treat migraine patients in a standardized way. The Consensus proposed well-defined criteria for resistant migraine (i.e., patients who do not respond to some treatment but who have residual therapeutic opportunities) and refractory migraine (i.e., patients who still have debilitating migraine despite maximal treatment efforts). The aim of this study was to better understand the perceived impact of resistant and refractory migraine and the attitude of physicians involved in migraine care toward those conditions.METHODS: We conducted a web-questionnaire-based cross-sectional international study involving physicians with interest in headache care.RESULTS: There were 277 questionnaires available for analysis. A relevant proportion of participants reported that patients with resistant and refractory migraine were frequently seen in their clinical practice (49.5% for resistant and 28.9% for refractory migraine); percentages were higher when considering only those working in specialized headache centers (75% and 46% respectively). However, many physicians reported low or moderate confidence in managing resistant (8.1% and 43.3%, respectively) and refractory (20.7% and 48.4%, respectively) migraine patients; confidence in treating resistant and refractory migraine patients was different according to the level of care and to the number of patients visited per week. Patients with resistant and refractory migraine were infrequently referred to more specialized centers (12% and 19%, respectively); also in this case, figures were different according to the level of care.CONCLUSIONS: This report highlights the clinical relevance of difficult-to-treat migraine and the presence of unmet needs in this field. There is the need of more evidence regarding the management of those patients and clear guidance referring to the organization of care and available opportunities.

AB - BACKGROUND: New treatments are currently offering new opportunities and challenges in clinical management and research in the migraine field. There is the need of homogenous criteria to identify candidates for treatment escalation as well as of reliable criteria to identify refractoriness to treatment. To overcome those issues, the European Headache Federation (EHF) issued a Consensus document to propose criteria to approach difficult-to-treat migraine patients in a standardized way. The Consensus proposed well-defined criteria for resistant migraine (i.e., patients who do not respond to some treatment but who have residual therapeutic opportunities) and refractory migraine (i.e., patients who still have debilitating migraine despite maximal treatment efforts). The aim of this study was to better understand the perceived impact of resistant and refractory migraine and the attitude of physicians involved in migraine care toward those conditions.METHODS: We conducted a web-questionnaire-based cross-sectional international study involving physicians with interest in headache care.RESULTS: There were 277 questionnaires available for analysis. A relevant proportion of participants reported that patients with resistant and refractory migraine were frequently seen in their clinical practice (49.5% for resistant and 28.9% for refractory migraine); percentages were higher when considering only those working in specialized headache centers (75% and 46% respectively). However, many physicians reported low or moderate confidence in managing resistant (8.1% and 43.3%, respectively) and refractory (20.7% and 48.4%, respectively) migraine patients; confidence in treating resistant and refractory migraine patients was different according to the level of care and to the number of patients visited per week. Patients with resistant and refractory migraine were infrequently referred to more specialized centers (12% and 19%, respectively); also in this case, figures were different according to the level of care.CONCLUSIONS: This report highlights the clinical relevance of difficult-to-treat migraine and the presence of unmet needs in this field. There is the need of more evidence regarding the management of those patients and clear guidance referring to the organization of care and available opportunities.

KW - Consensus

KW - Cross-Sectional Studies

KW - Headache

KW - Humans

KW - Migraine Disorders/diagnosis

KW - Surveys and Questionnaires

KW - Migraine care

KW - Migraine

KW - Refractory migraine

KW - Resistant migraine

UR - http://www.scopus.com/inward/record.url?scp=85106169511&partnerID=8YFLogxK

U2 - 10.1186/s10194-021-01252-4

DO - 10.1186/s10194-021-01252-4

M3 - Journal article

C2 - 34006218

VL - 22

SP - 39

JO - The Journal of Headache and Pain Online

JF - The Journal of Headache and Pain Online

SN - 1129-2377

IS - 1

M1 - 39

ER -

ID: 65837948